Market Place
Sourcing Support
Aurobindo Pharma’s Generics Cariprazine Receives Approval in US
16 Dec 2025 //
FDA
Ibsa Inst Bio’s Vybrique Receives Approval in US
16 Dec 2025 //
FDA
Ascent’ Generics Buprenorphine & Naloxone Receives Approval in US
15 Dec 2025 //
FDA
Lib ,’s Biologics Lerochol Receives Approval in US
12 Dec 2025 //
FDA
Entasis Therap’s Nuzolvence Receives Approval in US
12 Dec 2025 //
FDA
Milestone Pharma ,’s Cardamyst Receives Approval in US
12 Dec 2025 //
FDA
Amneal’s Generics Deflazacort Receives Approval in US
12 Dec 2025 //
FDA
Mylan’s Generics Octreotide Acetate Receives Approval in US
12 Dec 2025 //
FDA
Amphastar Pharms’ Generics Teriparatide Receives Approval in US
12 Dec 2025 //
FDA
Senores Pharms’ Generics Deferiprone Receives Approval in US
11 Dec 2025 //
FDA
Acadia Pharms’ Daybue Stix Receives Approval in US
11 Dec 2025 //
FDA
Biocryst Pharma,’s Orladeyo Receives Approval in US
11 Dec 2025 //
FDA
Micro’s Generics Lopinavir And Ritonavir Receives Approval in US
11 Dec 2025 //
FDA
Novitium Pharma’s Generics Omeprazole Receives Approval in US
10 Dec 2025 //
FDA
Specgx’s Generics Buprenorphine HCl Receives Approval in US
10 Dec 2025 //
FDA
Alembic’s Generics Loteprednol Etabonate Receives Approval in US
10 Dec 2025 //
FDA
Sunshine’s Generics Mirabegron Receives Tentative Approval in US
10 Dec 2025 //
FDA
Deva As’ Generics Isoproterenol HCl Receives Approval in US
10 Dec 2025 //
FDA
Aurobindo’s Generics Dapagliflozin Receives Approval in US
10 Dec 2025 //
FDA
Macleods’s Generics Doxycycline Hyclate Receives Approval in US
09 Dec 2025 //
FDA
Cipla’s Generics Rifaximin Receives Tentative Approval in US
08 Dec 2025 //
FDA
Caplin’s Generics Linezolid Receives Approval in US
08 Dec 2025 //
FDA
Apotex’s Generics Linagliptin Receives Tentative Approval in US
08 Dec 2025 //
FDA
Amneal’s Generics Epinephrine Receives Approval in US
08 Dec 2025 //
FDA
Teva Pharms’ Generics Estradiol Receives Approval in US
08 Dec 2025 //
FDA
Caplin’s Generics Acetaminophen Receives Approval in US
05 Dec 2025 //
FDA
Bion’s Generics Carbidopa Receives Tentative Approval in US
04 Dec 2025 //
FDA
Hopewell’s Generics Cladribine Receives Tentative Approval in US
04 Dec 2025 //
FDA
Mylan’s Generics Macitentan Receives Approval in US
03 Dec 2025 //
FDA
MSN’s Generics Brivaracetam Receives Tentative Approval in US
01 Dec 2025 //
FDA
Mankind’s Generics Sugammadex Receives Tentative Approval in US
01 Dec 2025 //
FDA
Amneal’s Generics Albuterol Sulfate Receives Approval in US
01 Dec 2025 //
FDA
Otsuka Pharm’s Biologics Voyxact Receives Approval in US
25 Nov 2025 //
FDA
Zydus’ Generics Verapamil HCl Receives Approval in US
24 Nov 2025 //
FDA
Alembic Pharms’ Generics Dapagliflozin Receives Approval in US
24 Nov 2025 //
FDA
Micro’s Generics Olmesartan Medoxomil Receives Approval in US
24 Nov 2025 //
FDA
Apotex’s Ruxolitinib Receives Approval in US
21 Nov 2025 //
FDA
Inventia Hlthcare Generics Dapagliflozin Receives Approval in US
21 Nov 2025 //
FDA
Alvotech USA`s Ustekinumab Receives BLA Approval in US
21 Nov 2025 //
FDA
Aurobindo`s Generics Potassium Chloride Receives Approval in US
20 Nov 2025 //
FDA
Xiromed’s Generics Clobetasol Propionate Receives Approval in US
20 Nov 2025 //
FDA
Accord BioPharma Ustekinumab Receives BLA Approval in US
20 Nov 2025 //
FDA
BioMarin Pharm`s Pegvaliase-pqpz BLA Receives Approval in US
20 Nov 2025 //
FDA
Bayer Pharm’s Hyrnuo Receives Approval in US
19 Nov 2025 //
FDA
Msn’s Generics Nilotinib HCl Receives Approval in US
19 Nov 2025 //
FDA
Dr Reddy’s Generics Nilotinib HCl Receives Approval in US
19 Nov 2025 //
FDA
Macleods’s Generics Doxycycline Hyclate Receives Approval in US
19 Nov 2025 //
FDA
Rising’s Generics Dichlorphenamide Receives Approval in US
18 Nov 2025 //
FDA
Hetero Iii’s Generics Fluphenazine HCl Receives Approval in US
18 Nov 2025 //
FDA
Arrowhead Pharma’s Redemplo Receives Approval in US
18 Nov 2025 //
FDA
Msn’s Generics Sitagliptin & Metformin Receives Approval in US
17 Nov 2025 //
FDA
Marksans Pharma’s Generics Loperamide HCl Receives Approval in US
17 Nov 2025 //
FDA
Biocon’s Generics Tofacitinib Receives Tentative Approval in US
17 Nov 2025 //
FDA
Mylan’s Generics Aprepitant Receives Tentative Approval in US
17 Nov 2025 //
FDA
HLS Therapeutics`s Nilemdo Approved in Canada
14 Nov 2025 //
HEALTH CANADA
Sandoz’s Generics Upadacitinib Receives Approval in US
14 Nov 2025 //
FDA
Hainan Poly Pharm’s Generics Voriconazole Receives Approval in US
14 Nov 2025 //
FDA
Accord’s Generics Lenalidomide Receives Approval in US
14 Nov 2025 //
FDA
Alembic’s Generics Diltiazem HCl Receives Approval in US
14 Nov 2025 //
FDA
Aurobindo Pharma’s Generics Fosfomycin Receives Approval in US
14 Nov 2025 //
FDA
